BILLS-110hr2900pcs.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (50)
02:14 Jul 17, 2007
VerDate Aug 31 2005
annual
2007
fiscal year
30 days
later than 180 days
2012
30-day
later than 30 days
fiscal year 2009
fiscal year 2008
later than 1 year
a fiscal year
such fiscal year
each fiscal year
six months
180-day
later than 90 days
15 days
2009
12-month
11
year
the next fiscal year
fiscal year 2007
later than 120 days
annually
fiscal years
October 1, 2007
later than 60 days
the fiscal year
October 1, 2012
one-year
each year
2003
fiscal year 2012
October 1
later than 5 days
one year
December 31
fiscal year 2006
6-month
2 years
one-half years
16
year
120 days
the end of the
2-year
three years
EVENT (7)
the ‘‘Act
the ‘‘Pediatric Research
the ‘‘Best Pharmaceuticals
the ‘‘Food and Drug Ad-
SESSION
H. R. 2900
the ‘‘Pediatric Medical
the ‘‘Administra-
8
FAC (1)
502(4
GPE (16)
United States
the United States
Pediatric
the District of Columbia
Founda-
24
States
CONTENTS.—A
the United States of America
Foun-
LA-
6
Treas-
the District of Columbia Circuit
LA-
3
cludes
U.S.
LOC (2)
appro-
3
appro-
11
NORP (5)
Cosmetic
510(k
FUNDING.—The
APPROPRIATIONS.—To
Indian
ORG (50)
SEC
the Federal Food, Drug
U.S.C.
the Food and Drug Administration
Congress
NIH
Food and Drug Administration
Foundation
Drug Administration
DTC
Food and Drugs
Federal
the Public Health Service Act
Labor
Senate
Board
the House of Representatives
Health and Human Services
the Federal Register
the Federal Food
the Pediatric Advisory Committee
GENERAL.—If
Food, Drug
the Food and Drug Administra-
Federal Food, Drug
Office
the Committee on Health, Education
the Committee on Energy
the Best Pharmaceuticals for Children Act
the National Institutes of Health
State
uct
National Institutes of Health
the Best Pharmaceuticals
House
the Committee on Health
United
the Commissioner of Food
the Food and Drug Admin-
Pediatric Advisory Committee
Health
Drug
Federal Register
the Food and Drug
the Pediatric Advisory
-Udall Foundation
Office of Pediatric Therapeutics
Healthcare Research and Quality
Committee
PERSON (7)
Reagan
mary
SIBLE.—If
Subparagraph
LORRAINE C. MILLER
ting
Topic Classifications
congressional legislation
95.6%
government oversight
27.4%
public health
17.3%
Extracted Keywords
postmarket
pediatric
user fee
drugs
fee amendments
pcs
bills pcs
drugs sec
medical devices
clinical trial
device
drug
medical device
user
food drug
Forensic Analysis
Classification Stamps
EXEMPT
PDF Metadata
- Creator
- ACOMP.exe WinVer 1c15 Aug 31 2005
- ModDate
- D:20230110184212Z
- Producer
- Acrobat Distiller 4.0 for Windows; modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20070718150238Z
Sentiment
Polarity
Neutral
-0.037
Subjectivity
51%
Subjective
No crisis correlations found for this document.
The ML pipeline may still be processing.